v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2024   33,629,169      
Beginning balance at Dec. 31, 2024 $ 1,366,974 $ 34 $ 827,796 $ 537,184 $ 1,960
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 16,551     16,551  
Stock-based compensation 1,201   1,210 (9)  
Issuance of restricted and deferred stock units (in shares)   31,587      
Issuance of restricted and deferred stock units (908)   (908)    
Employee stock purchase plan (in shares)   26,129      
Employee stock purchase plan 1,116   1,116    
Common stock issuance, net of costs (in shares)   495,900      
Common stock issuance, net of costs 26,545   26,545    
Dividends paid (14,142)     (14,142)  
Ending balance (in shares) at Mar. 31, 2025   34,182,785      
Ending balance at Mar. 31, 2025 1,397,337 $ 34 855,759 539,584 1,960
Beginning balance (in shares) at Dec. 31, 2024   33,629,169      
Beginning balance at Dec. 31, 2024 1,366,974 $ 34 827,796 537,184 1,960
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 86,358        
Ending balance (in shares) at Sep. 30, 2025   35,805,089      
Ending balance at Sep. 30, 2025 1,523,663 $ 36 941,759 579,908 1,960
Beginning balance (in shares) at Mar. 31, 2025   34,182,785      
Beginning balance at Mar. 31, 2025 1,397,337 $ 34 855,759 539,584 1,960
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 24,675     24,675  
Stock-based compensation 1,455   1,464 (9)  
Issuance of restricted and deferred stock units (in shares)   16,702      
Issuance of restricted and deferred stock units (61)   (61)    
Common stock issuance, net of costs (in shares)   1,087,593      
Common stock issuance, net of costs 57,169 $ 1 57,168    
Dividends paid (14,604)     (14,604)  
Ending balance (in shares) at Jun. 30, 2025   35,287,080      
Ending balance at Jun. 30, 2025 1,465,971 $ 35 914,330 549,646 1,960
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 45,132     45,132  
Stock-based compensation 1,979   1,988 (9)  
Issuance of restricted and deferred stock units (in shares)   418      
Issuance of restricted and deferred stock units 1   1    
Employee stock purchase plan (in shares)   24,732      
Employee stock purchase plan 1,015   1,015    
Common stock issuance, net of costs (in shares)   492,859      
Common stock issuance, net of costs 24,426 $ 1 24,425    
Dividends paid (14,861)     (14,861)  
Ending balance (in shares) at Sep. 30, 2025   35,805,089      
Ending balance at Sep. 30, 2025 $ 1,523,663 $ 36 941,759 579,908 1,960
Beginning balance (in shares) at Dec. 31, 2025 36,118,242 36,118,242      
Beginning balance at Dec. 31, 2025 $ 1,540,771 $ 36 958,188 581,080 1,467
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 19,013     19,013  
Stock-based compensation 1,202   1,212 (10)  
Issuance of restricted and deferred stock units (in shares)   37,809      
Issuance of restricted and deferred stock units (616)   (616)    
Employee stock purchase plan (in shares)   23,112      
Employee stock purchase plan 1,023   1,023    
Common stock issuance, net of costs (in shares)   5,660,377      
Common stock issuance, net of costs 288,601 $ 6 288,595    
Dividends paid (15,912)     (15,912)  
Ending balance (in shares) at Mar. 31, 2026   41,839,540      
Ending balance at Mar. 31, 2026 $ 1,834,082 $ 42 1,248,402 584,171 1,467
Beginning balance (in shares) at Dec. 31, 2025 36,118,242 36,118,242      
Beginning balance at Dec. 31, 2025 $ 1,540,771 $ 36 958,188 581,080 1,467
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income $ 88,646        
Ending balance (in shares) at Sep. 30, 2026 48,318,991 48,318,991      
Ending balance at Sep. 30, 2026 $ 2,201,216 $ 48 1,582,745 616,956 1,467
Beginning balance (in shares) at Mar. 31, 2026   41,839,540      
Beginning balance at Mar. 31, 2026 1,834,082 $ 42 1,248,402 584,171 1,467
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 26,589     26,589  
Stock-based compensation 1,706   1,715 (9)  
Issuance of restricted and deferred stock units (in shares)   13,313      
Issuance of restricted and deferred stock units (62)   (62)    
Common stock issuance, net of costs (2)   (2)    
Dividends paid (18,411)     (18,411)  
Ending balance (in shares) at Jun. 30, 2026   41,852,853      
Ending balance at Jun. 30, 2026 1,843,902 $ 42 1,250,053 592,340 1,467
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 43,044     43,044  
Stock-based compensation 1,750   1,750 0  
Issuance of restricted and deferred stock units (in shares)   7,003      
Issuance of restricted and deferred stock units (100)   (100)    
Employee stock purchase plan (in shares)   19,827      
Employee stock purchase plan 1,034   1,034    
Common stock issuance, net of costs (in shares)   6,439,308      
Common stock issuance, net of costs 330,014 $ 6 330,008    
Dividends paid $ (18,428)     (18,428)  
Ending balance (in shares) at Sep. 30, 2026 48,318,991 48,318,991      
Ending balance at Sep. 30, 2026 $ 2,201,216 $ 48 $ 1,582,745 $ 616,956 $ 1,467